0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 181-200 of 522 Articles
Research Letters |  FREE
Jeremy D. Keenan, MD, MPH; Paul M. Emerson, PhD; Bruce D. Gaynor, MD; et al.
JAMA Intern Med. 2013;173(9):821-823. doi:10.1001/jamainternmed.2013.3041.

Original Investigation |  FREE
Sejal Chowdhary, BS; Bolanle Bukoye, MPH, BS; Arjun M. Bhansali, MD; et al.
JAMA Intern Med. 2013;173(9):771-776. doi:10.1001/jamainternmed.2013.75.

Original Investigation |  FREE
Sarah D. Berry, MD, MPH; Yoojin Lee, MS, MPH; Shubing Cai, PhD; et al.
JAMA Intern Med. 2013;173(9):754-761. doi:10.1001/jamainternmed.2013.3795.

Invited Commentary | 
Eric Widera, MD
JAMA Intern Med. 2013;173(9):761-762. doi:10.1001/jamainternmed.2013.3801.

Original Investigation |  FREE
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
JAMA Intern Med. 2013;173(8):639-646. doi:10.1001/jamainternmed.2013.3283.
Includes: Supplemental Content

Invited Commentary | 
Susanna C. Larsson, PhD
JAMA Intern Med. 2013;173(8):647-648. doi:10.1001/jamainternmed.2013.3769.

Editor's Correspondence | 
Roy C. Ziegelstein, MD, MACP
JAMA Intern Med. 2013;173(8):713-714. doi:10.1001/jamainternmed.2013.3785.

Research Letters |  FREE
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
JAMA Intern Med. 2013;173(8):704-706. doi:10.1001/jamainternmed.2013.2807.
Includes: Supplemental Content

Original Investigation |  FREE
Nick Daneman, MD, MSc; Andrea Gruneir, PhD; Susan E. Bronskill, PhD; et al.
JAMA Intern Med. 2013;173(8):673-682. doi:10.1001/jamainternmed.2013.3029.

Invited Commentary | 
Carmel M. Hughes, PhD; Michael M. Tunney, PhD
JAMA Intern Med. 2013;173(8):682-683. doi:10.1001/jamainternmed.2013.4077.

Original Investigation |  FREE
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720.
Includes: Supplemental Content

Editor's Correspondence | 
Joseph V. Rodricks, PhD; Michael H. Lumpkin, PhD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.2533.

Editor's Correspondence | 
Pieter A. Cohen, MD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.3776.

Editor's Correspondence | 
Aaron S. Geller, MD
JAMA Intern Med. 2013;173(7):595-596. doi:10.1001/jamainternmed.2013.3045.

Editor's Correspondence | 
Jane C. Ballantyne, MD, FRCA; Mark D. Sullivan, MD, PhD; Andrew Kolodny, MD
JAMA Intern Med. 2013;173(7):595-596. doi:10.1001/jamainternmed.2013.3207.

Editor's Correspondence | 
J. Simon Bell, PhD
JAMA Intern Med. 2013;173(7):596-597. doi:10.1001/jamainternmed.2013.3280.

Invited Commentary | 
Amy Linsky, MD, MSc; Steven R. Simon, MD, MPH
JAMA Intern Med. 2013;173(7):524-525. doi:10.1001/jamainternmed.2013.4068.

Invited Commentary | 
Belinda Gier, PhD; Peter C. Butler, MD
JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374.

Research Letters |  FREE
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
JAMA Intern Med. 2013;173(7):586-588. doi:10.1001/jamainternmed.2013.2797.
Includes: Supplemental Content

Original Investigation |  FREE
Gregory S. Cooper, MD; Tzuyung D. Kou, PhD; Douglas K. Rex, MD
JAMA Intern Med. 2013;173(7):551-556. doi:10.1001/jamainternmed.2013.2908.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH